Boltz.bio Releases BoltzMol-1 and New Generation Drug Discovery AI Models
GabriCorso · x · 2026-07-04
boltz.bio hosted a launch event to introduce BoltzMol-1 for small molecule hit discovery, alongside another new model achieving state-of-the-art performance. Designed specifically for the drug discovery field, these models represent the latest advancements in biological AI.
More from Research
- NUS builds a soft force sensor that drives actuators without electronics or power — CurieuxExplorer · 2026-07-27
- Chelsea Finn says robot RL is bottlenecked by physical rollout cost, not algorithms — ycombinator · 2026-07-27
- ICML 2026 oral paper replication scores stay middling after a stricter re-scoring — profjamesevans · 2026-07-27
- Long-running agents will need immutable event logs, this thread argues — sebpaquet · 2026-07-27
- Seed IQ navigates Doom II, prompting questions about benchmarks beyond ARC-AGI — Fit_Transition8824 · 2026-07-27
- Agentic Data Science in Practice: Agents Write Code but Answer Wrong Questions — hugobowne · 2026-07-27